DOAC

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Azfar Zaman , Bernard Prendergast , David Hildick-Smith , et al

Read time: 14 Mins
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3m 29s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

Watch time: 7m 44s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

Philippe Garot , Bertrand Cormier , Jérôme Horvilleur ,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Watch time: 17m 13s

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy, et al

Watch time: 51m 8s
AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Watch time: 4m 8s
AHA 2019: Clinical Data Update on TWILIGHT and TWILIGHT-ACS

Marc P Bonaca, Roxana Mehran,

Watch time: 5m 5s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Azfar Zaman , Bernard Prendergast , David Hildick-Smith , et al

Read time: 14 Mins
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Philippe Garot , Bertrand Cormier , Jérôme Horvilleur ,

ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3m 29s

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy, et al

Watch time: 51m 8s
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

Watch time: 7m 44s
Dual Antithrombotic Therapy With Dabigatran

Christopher P Cannon,

Watch time: 5m 44s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Watch time: 17m 13s
AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Watch time: 4m 8s
View from the Thoraxcenter - What's hot at ESC 2019

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 18m 17s

Articles

Anti-thrombotic Therapy Following TAVI: UK and Ireland Consensus Statement

Azfar Zaman

,

Bernard Prendergast

,

David Hildick-Smith

,

Daniel J Blackman

,

Richard Anderson

,

Mark Spence

,

Darren Mylotte

,

David Smith

,

Ben Wilding

,

Chris Chapman

,

Kirsty Atkins

,

Kevin G Pollock

,

Ayesha C Qureshi

,

Adrian P Banning

,

Published:

10 April 2023

Citation:

Interventional Cardiology 2023;18:e13.

DOI:

https://doi.org/10.15420/icr.2022.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1202
  • Downloads: Downloads 89
  • Citations: 1
  • Read time: 14 Mins

Device-Related Thrombus After Left Atrial Appendage Closure

Philippe Garot

,

Bertrand Cormier

,

Jérôme Horvilleur

,

Published:

25 February 2019

Citation:

Interventional Cardiology Review 2019;14(1):42–4

DOI:

https://doi.org/10.15420/icr.2018.21.3
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 814
  • Downloads: Downloads 3
  • Citations: 15